Shattuck says the placement could fund operations into 2029 if all warrants are exercised. Two new directors join the board, including OrbiMed's Mona Ashiya, and four directors leave.
Latest Shattuck Labs news
We have not published a story on Shattuck Labs yet. When there is news, it will appear here.
Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $63.3 million.
Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.
Questions about Shattuck Labs
Has Shattuck Labs raised money recently?
Our latest story on this, dated Aug 26, 2025: "Shattuck Labs closes private placement of up to $103 million led by OrbiMed". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Shattuck Labs?
Shattuck Labs, Inc. trades under the ticker STTK on NASDAQ.
Where is Shattuck Labs listed?
Shattuck Labs, Inc. is listed on NASDAQ.
What is the SEC CIK of Shattuck Labs?
The SEC Central Index Key (CIK) for Shattuck Labs, Inc. is 1680367. Its filings are on SEC EDGAR.
How many shares does Shattuck Labs have outstanding?
100,363,253 shares as of 2026-08-07, per the cover page of its 10-Q filed 2026-08-11.
Which country or territory is Shattuck Labs listed under?
Our directory records Shattuck Labs, Inc. under United States.
What does Shattuck Labs do?
Our directory classifies Shattuck Labs, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Shattuck Labs?
The ISIN recorded for Shattuck Labs, Inc. is US82024L1035.
Does aibio.space cover Shattuck Labs?
aibio.space lists Shattuck Labs, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Shattuck Labs incorporated?
SEC records list its state or country of incorporation as DE.
What was Shattuck Labs's revenue last year?
$1.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Shattuck Labs profitable?
Shattuck Labs, Inc. reported a net loss of $48.8 million for the fiscal year ended Dec 31, 2025, and used $39.9 million of cash in operations, per its annual report to the SEC.
How much does Shattuck Labs spend on research and development?
$35.3 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Shattuck Labs have?
$63.3 million in cash at Jun 30, 2026, per its 10-Q.
What is the latest Shattuck Labs (STTK) stock news?
Our latest story on Shattuck Labs, dated Aug 26, 2025: "Shattuck Labs closes private placement of up to $103 million led by OrbiMed". Shattuck says the placement could fund operations into 2029 if all warrants are exercised. Two new directors join the board, including OrbiMed's Mona Ashiya, and four directors leave. Source.
Investor discussion: Shattuck Labs
Members talk about Shattuck Labs (STTK). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Shattuck Labs, newest first. Each line links the filing it comes from.
Reported a financing. SEC Form 8-K (Items 5.02,7.01,9.01). Source
Financings
Reported a financing. SEC Form 8-K (Items 1.01,3.02,7.01,9.01). Source
Financings
Filed a final prospectus for a securities offering. SEC Form 424B5. Source
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:STTK on TradingView.
SEC filings and registration
SEC name
Shattuck Labs, Inc.
CIK
1680367
Industry (SIC)
Pharmaceutical Preparations (2834)
US tickers
STTK (Nasdaq)
State or country of incorporation
DE
Fiscal year ends
December 31
Filer category
Non-accelerated filer<br>Smaller reporting company
Business address
500 W. 5TH STREET, AUSTIN, TX, 78701
Phone
512-900-4690
Shares outstanding
100,363,253 as of 2026-08-07 (10-Q filed 2026-08-11)
Former names
Shattuck Labs, Inc.
Recent filings (8-K and 6-K are the company's own announcements)
Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.
Listing details
Shattuck Labs, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker STTK, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio